清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Mechanical thrombectomy for the treatment of primary and secondary distal medium-vessel occlusion stroke: systematic review and meta-analysis

医学 冲程(发动机) 荟萃分析 溶栓 置信区间 改良兰金量表 脑出血 闭塞 子群分析 内科学 外科 心肌梗塞 缺血性中风 缺血 蛛网膜下腔出血 工程类 机械工程
作者
Aarón Rodríguez-Calienes,Juan Vivanco‐Suarez,J Sequeiros,Milagros Galecio‐Castillo,Cynthia Zevallos,Mudassir Farooqui,Santiago Ortega‐Gutiérrez
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:15 (e3): e460-e467 被引量:39
标识
DOI:10.1136/jnis-2022-019975
摘要

Background There is limited evidence on the indication and role of mechanical thrombectomy (MT) in patients with distal medium-vessel occlusions (DMVOs). The aim of this systematic review and meta-analysis was to evaluate all the evidence available on the efficacy and safety of MT techniques (stent retriever, aspiration) in primary and secondary DMVOs. Methods Five databases were searched from inception to January 2023 for studies of MT in primary and secondary DMVOs. Outcomes of interest included favorable functional outcome (90-day modified Rankin scale (mRS) 0–2), successful reperfusion (modified Thrombolysis in Cerebral Infarction (mTICI) 2b-3), symptomatic intracerebral hemorrhage (sICH), and 90-day mortality. Prespecified subgroup meta-analyses according to the specific MT technique and to the vascular territory (distal M2-M5, A2-A5, P2-P5) were also performed. Results A total of 29 studies with 1262 patients were included. For primary DMVOs (n=971 patients), pooled rates of successful reperfusion, favorable outcome, 90-day mortality and sICH were 84% (95% confidence interval (CI) 76 to 90%), 64% (95% CI 54 to 72%), 12% (95% CI 8 to 18%), and 6% (95% CI 4 to 10%), respectively. For secondary DMVOs (n=291 patients), pooled rates of successful reperfusion, favorable outcome, 90-day mortality and sICH were 82% (95% CI 73 to 88%), 54% (95% CI 39 to 69%), 11% (95% CI 5 to 20%), and 3% (95% CI 1 to 9%), respectively. Subgroup analyses by MT technique and by vascular territory showed no differences in primary and secondary DMVOs. Conclusion Our findings suggest that MT using aspiration or stent retriever techniques appears to be effective and safe in primary and secondary DMVOs. However, given the level of evidence of our results, further confirmation in well-designed randomized controlled trials is needed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
笑傲完成签到,获得积分10
6秒前
1024504036完成签到,获得积分10
17秒前
琳llin完成签到 ,获得积分10
30秒前
明亮的小兔子完成签到 ,获得积分10
36秒前
五月完成签到,获得积分10
41秒前
mochalv123完成签到 ,获得积分10
1分钟前
mochalv123完成签到 ,获得积分10
1分钟前
mochalv123完成签到 ,获得积分10
1分钟前
mochalv123完成签到 ,获得积分10
1分钟前
科研通AI6.2应助北极星采纳,获得10
1分钟前
1分钟前
北极星发布了新的文献求助10
2分钟前
2分钟前
阿豪要发文章完成签到 ,获得积分10
3分钟前
Victor3发布了新的文献求助30
3分钟前
yolo完成签到,获得积分10
3分钟前
Criminology34应助June采纳,获得10
3分钟前
呆萌如容完成签到,获得积分10
4分钟前
李爱国应助科研通管家采纳,获得10
4分钟前
请输入昵称完成签到 ,获得积分10
4分钟前
Freedom完成签到 ,获得积分10
4分钟前
王誉霖完成签到,获得积分10
4分钟前
4分钟前
June完成签到,获得积分10
4分钟前
似水流年完成签到 ,获得积分10
4分钟前
朴素的语兰完成签到,获得积分10
5分钟前
5分钟前
loii完成签到,获得积分0
6分钟前
超超完成签到 ,获得积分10
6分钟前
酷酷海豚完成签到,获得积分10
6分钟前
闪闪的水彤完成签到,获得积分10
6分钟前
楚科研完成签到 ,获得积分10
7分钟前
简啦啦发布了新的文献求助20
7分钟前
怡然碧空完成签到,获得积分10
7分钟前
知行者完成签到 ,获得积分10
7分钟前
Ava应助科研通管家采纳,获得10
8分钟前
漠尘完成签到,获得积分10
8分钟前
儒雅的月光完成签到,获得积分10
8分钟前
woxinyouyou完成签到,获得积分0
8分钟前
8分钟前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Matrix Methods in Data Mining and Pattern Recognition 510
Social Skills Improvement System-Rating Scales--Chinese Version 500
Dynamische Polarisation von H-1 und B-11 in (CH-3)-3NBH-3 500
CLSI M07 2024 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7247728
求助须知:如何正确求助?哪些是违规求助? 8870706
关于积分的说明 18712194
捐赠科研通 6926108
什么是DOI,文献DOI怎么找? 3197998
关于科研通互助平台的介绍 2373776
邀请新用户注册赠送积分活动 2172888